Search Results - Gilles Paintaud
- Showing 1 - 20 results of 25
- Go to Next Page
-
1
-
2
-
3
-
4
Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases by Émilie Ducourau, Denis Mulleman, Gilles Paintaud, Delphine Miow Lin, Francine Lauféron, David Ternant, Hervé Watier, Philippe Goupille
Published 2011Artigo -
5
Expression Profiling of Calcium Channels and Calcium-Activated Potassium Channels in Colorectal Cancer by Sajida Ibrahim, Hassan Dakik, Christophe Vandier, Romain Chautard, Gilles Paintaud, Frédéric Mazurier, Thierry Lecomte, Maxime Guéguinou, William Raoul
Published 2019Artigo -
6
The underlying inflammatory chronic disease influences infliximab pharmacokinetics by Christophe Passot, Denis Mulleman, Théodora Bejan‐Angoulvant, Alexandre Aubourg, S. Willot, Thierry Lecomte, Laurence Picon, Philippe Goupille, Gilles Paintaud, David Ternant
Published 2016Artigo -
7
Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20 by David Daydé, David Ternant, Marc Ohresser, Stéphanie Lerondel, Sabrina Pesnel, Hervé Watier, Alain Le Pape, P. Bardos, Gilles Paintaud, Guillaume Cartron
Published 2008Artigo -
8
Pharmacokinetics and concentration–effect relationship of adalimumab in rheumatoid arthritis by David Ternant, Émilie Ducourau, P. Fuzibet, Céline Vignault, Hervé Watier, Thierry Lequerré, Xavier Le Loët, Olivier Vittecoq, Philippe Goupille, Denis Mulleman, Gilles Paintaud
Published 2014Artigo -
9
Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial by Gert Van Assche, Charlotte Magdelaine–Beuzelin, Geert D’Haens, Filip Baert, Maja Noman, Séverine Vermeire, David Ternant, Hervé Watier, Gilles Paintaud, Paul Rutgeerts
Published 2008Artigo -
10
Influence of<i>FCGRT</i>gene polymorphisms on pharmacokinetics of therapeutic antibodies by Christophe Passot, Nicolas Azzopardi, Sylvaine Renault, Nadine Baroukh, Christophe Arnoult, Marc Ohresser, M. Boisdron‐Celle, Érick Gamelin, Hervé Watier, Gilles Paintaud, Valérie Gouilleux‐Gruart
Published 2013Artigo -
11
Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritis by David Ternant, Émilie Ducourau, Aleth Perdriger, Anca Corondan, Benoît Le Goff, Valérie Devauchelle‐Pensec, Elisabeth Solau‐Gervais, Hervé Watier, Philippe Goupille, Gilles Paintaud, Denis Mulleman
Published 2013Artigo -
12
Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease by Édouard Louis, Z. El Ghoul, Séverine Vermeire, Sébastien Dall’Ozzo, P. Rutgeerts, Gilles Paintaud, Jacques Bélaïche, Martine De Vos, A. Van Gossum, J.F. Colombel, Hervé Watier
Published 2004Artigo -
13
IgG1 Allotypes Influence the Pharmacokinetics of Therapeutic Monoclonal Antibodies through FcRn Binding by David Ternant, Christophe Arnoult, Martine Pugnière, Christine Dhommée, Daniel Drocourt, Éric Pérouzel, Christophe Passot, Nadine Baroukh, Denis Mulleman, Gérard Tiraby, Hervé Watier, Gilles Paintaud, Valérie Gouilleux‐Gruart
Published 2015Artigo -
14
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report by Mira Tout, Olivier Casasnovas, Michel Meignan, T. Lamy, Franck Morschhauser, Gilles Salles, Emmanuel Gyan, Corinne Haïoun, Mélanie Mercier, Pierre Feugier, Sami Boussetta, Gilles Paintaud, David Ternant, Guillaume Cartron
Published 2017Artigo -
15
Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease by Konstantinos Κarmiris, Gilles Paintaud, Maja Noman, Charlotte Magdelaine–Beuzelin, Marc Ferrante, Danielle Degenne, Karolien Claes, Tamara Coopman, Nele Van Schuerbeek, Gert Van Assche, Séverine Vermeire, Paul Rutgeerts
Published 2009Artigo -
16
ELLIPSE Study by Sophie Dupuis‐Girod, A. Ambrun, Évelyne Decullier, Géraldine Samson, Adeline Roux, Anne‐Emmanuelle Fargeton, Catherine Rioufol, Vérane Schwiertz, F. Disant, François Chapuis, Yves Donazzolo, Gilles Paintaud, Patrick Edery, Frédéric Faure
Published 2014Artigo -
17
Orthotopic liver transplantation for incurable alveolar echinococcosis of the liver: Report of 17 cases by Solange Bresson‐Hadni, Anne Minello Franza, Jean‐Philippe Miguet, Dominique A. Vuitton, D Lenys, Élisabeth Monnet, G. Landecy, Gilles Paintaud, P Rohmer, Marie-Claude Becker, J L Christophe, G. Mantion, M Gillet
Published 1991Artigo -
18
Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system by Laurent Guilleminault, Nicolas Azzopardi, Christophe Arnoult, Julien Sobilo, Virginie Hervé, J. Montharu, Antoine Guillon, Christian Andrés, Olivier Hérault, A. Le Pape, P. Diot, É. Lemarié, Gilles Paintaud, Valérie Gouilleux‐Gruart, Nathalie Heuzé-Vourc’h
Published 2014Artigo -
19
Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter... by Y. Benhamou, Gilles Paintaud, Élie Azoulay, Pascale Poullin, Lionel Galicier, Céline Desvignes, Jean‐Luc Baudel, Julie Peltier, Jean‐Paul Mira, Frédéric Pène, Claire Presne, Samir Saheb, C. Deligny, Alexandra Rousseau, Frédéric Féger, Agnès Veyradier, Paul Coppo
Published 2016Artigo -
20
Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped by Édouard Louis, Jean‐Yves Mary, Gwénola Vernier-Massouille, Jean–Charles Grimaud, Yoram Bouhnik, David Laharie, Jean‐Louis Dupas, Hélène Pillant, Laurence Picon, M Veyrac, Mathurin Flamant, Guillaume Savoye, Raymond Jian, M. Devos, Raphaël Porcher, Gilles Paintaud, Éric Piver, Jean–Frédéric Colombel, Marc Lémann
Published 2011Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Gastroenterology
Immunology
Pharmacokinetics
Pharmacology
Infliximab
Biology
Disease
Rheumatoid arthritis
Antibody
Surgery
Tumor necrosis factor alpha
Adalimumab
Chemotherapy
Crohn's disease
Randomized controlled trial
Methotrexate
Oncology
Ankylosing spondylitis
Arthritis
Bevacizumab
Environmental health
Gene
Immunogenicity
Inflammatory bowel disease
Lymphoma
Monoclonal antibody
Pathology
Pharmacodynamics